The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database
- PMID: 33046835
- PMCID: PMC7843417
- DOI: 10.1038/s10038-020-00849-y
The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database
Abstract
BRCA1/2 pathogenic variant prevalence in Japanese breast cancer is unclear. Here, we analyzed BRCA1/2 pathogenic variant prevalence with a particular focus on age factors, using the Japanese HBOC consortium database. All registered subjects were Japanese individuals who underwent BRCA1/2 genetic testing from January 1996 to July 2017 according to the Japanese HBOC consortium database. Cases were extracted and analyzed for each evaluation item. Overall BRCA1 and BRCA2 pathogenic variant prevalence was 11.2% and 9.0% in the cohort of 2366 proband patients, respectively. The age at onset of breast cancer for patients with BRCA1/2 pathogenic variants was significantly lower than that for patients without a BRCA1/2 pathogenic variant. In both BRCA1/2 patients, ages at onset were not statistically significantly different between two subtype groups (ER-positive vs. TNBC). We analyzed the BRCA1/2 pathogenic variant prevalence among age groups in patients with no family history of breast or ovarian cancer. In the TNBC group, the rate of genetic variants was more frequent among younger patients. Our results demonstrated that early breast cancer onset is associated with a BRCA1/2 pathogenic variant in the Japanese population. Younger TNBC patients were more likely to have a BRCA1/2 pathogenic variant irrespective of a family history of breast or ovarian cancer.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures



Similar articles
-
Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data.Breast Cancer Res Treat. 2025 Jan;209(1):177-188. doi: 10.1007/s10549-024-07485-6. Epub 2024 Oct 2. Breast Cancer Res Treat. 2025. PMID: 39356394
-
Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).PLoS One. 2021 Jan 11;16(1):e0236907. doi: 10.1371/journal.pone.0236907. eCollection 2021. PLoS One. 2021. PMID: 33428613 Free PMC article.
-
Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population.PLoS One. 2015 Jul 29;10(7):e0134408. doi: 10.1371/journal.pone.0134408. eCollection 2015. PLoS One. 2015. PMID: 26221963 Free PMC article.
-
Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario.Eur J Med Res. 2024 Mar 20;29(1):187. doi: 10.1186/s40001-024-01767-x. Eur J Med Res. 2024. PMID: 38504328 Free PMC article.
-
Germline Genetic Testing for Hereditary Breast and Ovarian Cancer: Current Concepts in Risk Evaluation.Cold Spring Harb Perspect Med. 2024 Aug 1;14(8):a041318. doi: 10.1101/cshperspect.a041318. Cold Spring Harb Perspect Med. 2024. PMID: 38151326 Review.
Cited by
-
Management of patients with BRCA mutation from the point of view of a breast surgeon.Ann Med Surg (Lond). 2021 Apr 16;65:102311. doi: 10.1016/j.amsu.2021.102311. eCollection 2021 May. Ann Med Surg (Lond). 2021. PMID: 33996049 Free PMC article. Review.
-
Risk-reducing decisions regarding germline BRCA pathogenic variant: focusing on the timing of genetic testing and RRSO.J Med Genet. 2024 Mar 21;61(4):392-398. doi: 10.1136/jmg-2023-109549. J Med Genet. 2024. PMID: 38124001 Free PMC article.
-
Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women.Front Genet. 2023 Jan 4;13:1039037. doi: 10.3389/fgene.2022.1039037. eCollection 2022. Front Genet. 2023. PMID: 36685821 Free PMC article.
-
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy.J Gynecol Oncol. 2022 Jul;33(4):e46. doi: 10.3802/jgo.2022.33.e46. Epub 2022 Mar 31. J Gynecol Oncol. 2022. PMID: 35557031 Free PMC article.
-
A transcriptional response to replication stress selectively expands a subset of Brca2-mutant mammary epithelial cells.Nat Commun. 2023 Aug 25;14(1):5206. doi: 10.1038/s41467-023-40956-w. Nat Commun. 2023. PMID: 37626143 Free PMC article.
References
-
- Breast Cancer Risk and Prevention. https://www.cancer.org/cancer/breast-cancer/risk-and-prevention.html. 2020.
-
- SEER Stat Fact Sheets. Female Breast Cancer. https://seer.cancer.gov/statfacts/html/breast.html. 2015–2017.
-
- National Cancer Center Japan. https://ganjoho.jp/reg_stat/statistics/stat/summary.html. (2017).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous